Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 14, 2013 - Issue 4
Submit an article Journal homepage
1,361
Views
43
CrossRef citations to date
0
Altmetric
Drug Evaluations

Aripiprazole in the treatment of Alzheimer's disease

Peter Paul De DeynUniversity of Groningen, University Medical Center Groningen, Alzheimer Research Center, Department of Neurology, 9713 GZ Groningen, The Netherlands+0031 50 3611707; [email protected];Middelheim General Hospital, ZNA, Department of Neurology/Memory Clinic, Lindendreef 1, B-2020 Antwerp, Belgium;University of Antwerp, Institute Born-Bunge, Department of Biomedical Sciences, Laboratory of Neurochemistry & Behaviour, Universiteitsplein 1, B-2610 Wilrijk, Belgium;University Medical Center Groningen, Alzheimer Research Center, Department of Neurology, Hanzeplein 1, 9713 GZ Groningen, The Netherlands
, MD PhD MMPR,
Annemieke FJ DrenthUniversity of Groningen, University Medical Center Groningen, Alzheimer Research Center, Department of Neurology, 9713 GZ Groningen, The Netherlands+0031 50 3611707; [email protected];University Medical Center Groningen, Alzheimer Research Center, Department of Neurology, 9713 GZ Groningen, The Netherlands
, MD,
Berry P KremerUniversity of Groningen, University Medical Center Groningen, Alzheimer Research Center, Department of Neurology, 9713 GZ Groningen, The Netherlands+0031 50 3611707; [email protected];University Medical Center Groningen, Alzheimer Research Center, Department of Neurology, Hanzeplein 1, 9713 GZ Groningen, The Netherlands
, MD PhD,
Richard C Oude VoshaarUniversity Center of Psychiatry & Interdisciplinary Center Psychopathology and Emotion regulation, University Medical Center Groningen, University of Groningen, 9700 RB Groningen, The Netherlands;University Medical Center Groningen, University of Groningen, Department of Psychiatry, 9700 RB Groningen, The Netherlands
, MD PhD &
Debby Van DamUniversity of Antwerp, Institute Born-Bunge, Department of Biomedical Sciences, Laboratory of Neurochemistry & Behaviour, Universiteitsplein 1, B-2610 Wilrijk, Belgium;University of Antwerp, Institute Born-Bunge, Department of Biomedical Sciences, Laboratory of Neurochemistry & Behaviour, Universiteitsplein 1, B-2610 Wilrijk, Belgium
, MSc PhD
Pages 459-474 | Published online: 28 Jan 2013

Citations (43)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Ricardo P. Garay, Leslie Citrome, George T. Grossberg, Icilio Cavero & Pierre-Michel Llorca. (2016) Investigational drugs for treating agitation in persons with dementia. Expert Opinion on Investigational Drugs 25:8, pages 973-983.
Read now
Abdullah Alghasham & Naila Rasheed. (2014) Stress-mediated modulations in dopaminergic system and their subsequent impact on behavioral and oxidative alterations: An update. Pharmaceutical Biology 52:3, pages 368-377.
Read now

Articles from other publishers (41)

Tarun Gupta, Varinder Singh, Mohamed Hefnawy, Mohammed M. Alanazi, Bader Alsuwayt, Atul Kabra, Amit Kumar, Chirag Pasricha & Ravinder Singh. (2023) Ameliorating the Role of Aripiprazole in Memory Deficits Induced by Intracerebroventricular Streptozotocin-Induced Dementia of Alzheimer’s Type. ACS Omega 8:28, pages 25295-25302.
Crossref
F. Trotta, L. Biscetti & A. Cherubini. 2023. Optimizing Pharmacotherapy in Older Patients. Optimizing Pharmacotherapy in Older Patients 269 287 .
Andi Liu, Astrid M Manuel, Yulin Dai, Brisa S Fernandes, Nitesh Enduru, Peilin Jia & Zhongming Zhao. (2022) Identifying candidate genes and drug targets for Alzheimer’s disease by an integrative network approach using genetic and brain region-specific proteomic data. Human Molecular Genetics 31:19, pages 3341-3354.
Crossref
Fan Zhang, Wei Hu & Yirong Liu. (2022) GCMM: graph convolution network based on multimodal attention mechanism for drug repurposing. BMC Bioinformatics 23:1.
Crossref
David C. Steffens & Kristina F. ZdanysBenoit Mulsant & Bruce Pollock. 2022. The American Psychiatric Association Publishing Textbook of Geriatric Psychiatry. The American Psychiatric Association Publishing Textbook of Geriatric Psychiatry.
Yizhou Jiang, Uma Gaur, Zhibai Cao, Sheng-Tao Hou & Wenhua Zheng. (2022) Dopamine D1- and D2-like receptors oppositely regulate lifespan via a dietary restriction mechanism in Caenorhabditis elegans. BMC Biology 20:1.
Crossref
Pavel Mohr, Jirí Masopust & Miloslav Kopeček. (2022) Dopamine Receptor Partial Agonists: Do They Differ in Their Clinical Efficacy?. Frontiers in Psychiatry 12.
Crossref
Kaléu Mormino Otoni, Karla Bruna Nogueira Torres Mormino, Sandna Larissa Freitas dos Santos & Maria Liliane Luciano Pereira. 2022. Pharmacological Treatment of Alzheimer's Disease. Pharmacological Treatment of Alzheimer's Disease 81 98 .
Karolina Maciejewska, Kamila Czarnecka & Paweł Szymański. (2021) A review of the mechanisms underlying selected comorbidities in Alzheimer’s disease. Pharmacological Reports 73:6, pages 1565-1581.
Crossref
Bryan McClarty, Guadalupe Rodriguez & Hongxin Dong. (2021) Dose Effects of Histone Deacetylase Inhibitor Tacedinaline (CI-994) on Antipsychotic Haloperidol-Induced Motor and Memory Side Effects in Aged Mice. Frontiers in Neuroscience 15.
Crossref
Martin Steinberg. (2021) Update on Pharmacological Treatment of Neuropsychiatric Symptoms of Dementia. Current Geriatrics Reports 10:2, pages 51-57.
Crossref
Li-Kai Huang, Shu-Ping Chao & Chaur-Jong Hu. (2020) Clinical trials of new drugs for Alzheimer disease. Journal of Biomedical Science 27:1.
Crossref
Myrlene Sanon Aigbogun, Martin Cloutier, Marjolaine Gauthier-Loiselle, Annie Guerin, Martin Ladouceur, Ross A. Baker, Michael Grundman, Ruth A. Duffy, Ann Hartry, Keva Gwin & Howard Fillit. (2020) Real-World Treatment Patterns and Characteristics Among Patients with Agitation and Dementia in the United States: Findings from a Large, Observational, Retrospective Chart Review. Journal of Alzheimer's Disease 77:3, pages 1181-1194.
Crossref
Xiangxiang Zeng, Siyi Zhu, Xiangrong Liu, Yadi Zhou, Ruth Nussinov & Feixiong Cheng. (2019) deepDR: a network-based deep learning approach to in silico drug repositioning . Bioinformatics 35:24, pages 5191-5198.
Crossref
Valeria Calsolaro, Rachele Antognoli, Chukwuma Okoye & Fabio Monzani. (2019) The Use of Antipsychotic Drugs for Treating Behavioral Symptoms in Alzheimer’s Disease. Frontiers in Pharmacology 10.
Crossref
Mathura T. Thiyagarajah, Nathan Herrmann, Myuri Ruthirakuhan, Abby Li & Krista L. Lanctôt. (2019) Novel Pharmacologic Strategies for Treating Behavioral Disturbances in Alzheimer’s Disease. Current Behavioral Neuroscience Reports 6:3, pages 72-87.
Crossref
Zahra Mortezaei, Jean‐Baptiste Cazier, Ali Ashraf Mehrabi, Chao Cheng & Ali Masoudi‐Nejad. (2018) Novel putative drugs and key initiating genes for neurodegenerative disease determined using network‐based genetic integrative analysis. Journal of Cellular Biochemistry 120:4, pages 5459-5471.
Crossref
Seema Zargar, Abdul-Rahman A. Al-Majed & Tanveer A. Wani. (2018) Potentiating and synergistic effect of grapefruit juice on the antioxidant and anti-inflammatory activity of aripiprazole against hydrogen peroxide induced oxidative stress in mice. BMC Complementary and Alternative Medicine 18:1.
Crossref
Antoni Benabarre, Jose Antonio Campos, Felicia Russo, Giancarlo Cerveri, Davide Prestia, Sergio González, Agustín Pérez-Sendino & Luis Gutiérrez-Rojas. (2018) Tratamiento con aripiprazol en la práctica clínica: consenso de un panel de expertos. Psiquiatría Biológica 25:3, pages 89-95.
Crossref
Hennekens Charles H. (2018) Antipsychotic Drug Therapies: Matching primary care practice to clinical challenges. Archives of Community Medicine and Public Health, pages 047-050.
Crossref
Sevda Sarikaya & Basar Sarikaya. (2018) Aripiprazole for the Treatment of Inappropriate Sexual Behavior: Case Report of an Alzheimer’s Disease Patient Known as Heterosexual with Recently Shifted Sexual Orientation to Same Gender. Journal of Alzheimer's Disease Reports 2:1, pages 117-121.
Crossref
Angela C. Golas & Corinne E. Fischer. (2018) Antipsychotic Pharmacotherapy for Neuropsychiatric Symptoms of Dementia. Current Treatment Options in Psychiatry 5:1, pages 56-72.
Crossref
Stephen J. Ralph & Anthony J. Espinet. (2018) Increased All-Cause Mortality by Antipsychotic Drugs: Updated Review and Meta-Analysis in Dementia and General Mental Health Care. Journal of Alzheimer's Disease Reports 2:1, pages 1-26.
Crossref
Jessica E. Waserman & Karen Saperson. 2018. Geriatric Psychiatry. Geriatric Psychiatry 305 318 .
So Youn Park, Hwa Kyoung Shin, Won Suk Lee, Sun Sik Bae, Koanhoi Kim, Ki Whan Hong & Chi Dae Kim. (2017) Neuroprotection by aripiprazole against β-amyloid-induced toxicity by P-CK2α activation via inhibition of GSK-3β. Oncotarget 8:66, pages 110380-110391.
Crossref
Naiem T. Issa, Jordan Kruger, Henri Wathieu, Rajarajan Raja, Stephen W. Byers & Sivanesan Dakshanamurthy. (2016) DrugGenEx-Net: a novel computational platform for systems pharmacology and gene expression-based drug repurposing. BMC Bioinformatics 17:1.
Crossref
Cornelis J. Van der Schyf. (2016) Psychotropic Drug Development Strategies that Target Neuropsychiatric Etiologies in Alzheimer's and Parkinson's Diseases. Drug Development Research 77:8, pages 458-468.
Crossref
Lieven D. Declercq, Rik Vandenberghe, Koen Van Laere, Alfons Verbruggen & Guy Bormans. (2016) Drug Development in Alzheimer’s Disease: The Contribution of PET and SPECT. Frontiers in Pharmacology 7.
Crossref
Mariyan K. Topolov & Damianka P. Getova. (2016) Cognitive Impairment in Schizophrenia, Neurotransmitters and the New Atypical Antipsychotic Aripiprazole. Folia Medica 58:1, pages 12-18.
Crossref
Joseph Trettel, Zeina Chemali & Kirk R. Daffner. 2016. Neurodegenerative Disorders. Neurodegenerative Disorders 233 253 .
Lin Tan, Lan Tan, Hui-Fu Wang, Jun Wang, Chen-Chen Tan, Meng-Shan Tan, Xiang-Fei Meng, Chong Wang & Jin-Tai Yu. (2015) RETRACTED ARTICLE: Efficacy and safety of atypical antipsychotic drug treatment for dementia: a systematic review and meta-analysis. Alzheimer's Research & Therapy 7:1.
Crossref
Yannick Vermeiren, Debby Van Dam, Tony Aerts, Sebastiaan Engelborghs, Jean-Jacques Martin & Peter P De Deyn. (2015) The monoaminergic footprint of depression and psychosis in dementia with Lewy bodies compared to Alzheimer’s disease. Alzheimer's Research & Therapy 7:1.
Crossref
Mark A. Colijn, Bradley H. Nitta & George T. Grossberg. (2015) Psychosis in Later Life. Harvard Review of Psychiatry 23:5, pages 354-367.
Crossref
Jennifer Rose V. Molano, Robin Bratt & Rhonna Shatz. (2015) Treatment and Management of Dementia Due to Alzheimer’s Disease. Current Treatment Options in Neurology 17:8.
Crossref
Mark Spengler, Michael Adler & Christof M. Niemeyer. (2015) Highly sensitive ligand-binding assays in pre-clinical and clinical applications: immuno-PCR and other emerging techniques. The Analyst 140:18, pages 6175-6194.
Crossref
Halil Bisgin, Zhichao Liu, Hong Fang, Reagan Kelly, Xiaowei Xu & Weida Tong. (2014) A phenome-guided drug repositioning through a latent variable model. BMC Bioinformatics 15:1.
Crossref
Yannick Vermeiren, Debby Van Dam, Tony Aerts, Sebastiaan Engelborghs & Peter P. De Deyn. (2014) Monoaminergic neurotransmitter alterations in postmortem brain regions of depressed and aggressive patients with Alzheimer's disease. Neurobiology of Aging 35:12, pages 2691-2700.
Crossref
Joshana K. Goga, Quyen Tran & Stephanie Walters. (2014) Treating the neuropsychiatric symptoms of dementia: A case based approach. Mental Health Clinician 4:4, pages 207-210.
Crossref
Subramoniam Madhusoodanan. (2014) Pharmacological management of behavioral symptoms associated with dementia. World Journal of Psychiatry 4:4, pages 72.
Crossref
Peter Paul De Deyn & Debby Van Dam. 2010. Encyclopedia of Psychopharmacology. Encyclopedia of Psychopharmacology 1 9 .
Sergio E. Starkstein & Jaime Pahissa. 2014. Movement Disorders in Dementias. Movement Disorders in Dementias 73 86 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.